At Nicolan, we are re-exploring healthcare to allow people nationwide to live better at each step of life. Our company representation is fed in the sector by our extensive market knowledge throughout India including in our Advanced Markets division, which consists of Navi Mumbai and Ghaziabad. Discover five impressions about our Advanced Markets division:
In Navi Mumbai, proceeds to be a powerful business within Nicolan, with a strategically focused green strength of 200 and a distinct portfolio of more than 300 quality-rich products, including brands, combined generics and biosimilars.
In Maharashtra, we provide medicines for patients traversing a wide range of significant therapeutic sectors, disseminated over various technologies and dosage information. We have a differentiated portfolio, and in India proceed to be a director in the retail pharmaceutical market ranking excellently in preference. We have also made notable investments in technologies to advance our robust pipeline.
Our Company is divided into three main areas: Gaziyabad, Jammu, and Navi Mumbai. We have a sales team of more than 3,000 associates working in larger than 20 states developing long standing connections that have enabled us to be a partner of preference to our clients.
Our product portfolio in India comprises more than 150+ medicines across a wide range of therapeutic fields. We have become one of the industry’s biggest and distinct biosimilar portfolios with a presence in Anti-Infectives, Calcium Supplements, Gastro Intestinal, Neuro/PSY, Pain/Analgesics, and Vitamins/Minerals. We are likewise a key professional beyond the region in the treatment of post-cancer-related problems in our procurement of medicinal portfolio, additional complementing and developing our compounded injectables delivery and supply in hospitals.
With a documented track experience of manufacturing high-quality medicines to clients all over India. Our workforce is well-positioned to develop on our authorized partnerships and brand stake to be a leader in manufacturing medicines to patients when and where they require them.
0 Comments